Issy les Moulineaux, France

Maurizio Ceppi

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Maurizio Ceppi: Innovator in Genomic Detection Technologies

Introduction

Maurizio Ceppi is a prominent inventor based in Issy les Moulineaux, France. He has made significant contributions to the field of genomic detection technologies, particularly in methods that enhance the understanding of genetic predispositions to various diseases.

Latest Patents

Ceppi holds 2 patents that focus on groundbreaking methods in genetic research. His first patent, titled "Methods for the detection of sequence amplification in the BRCA1 locus," outlines techniques for identifying amplifications in the BRCA1 locus. This method is crucial for determining predispositions to diseases such as ovarian and breast cancer. The second patent, "Method for identifying or detecting genomic rearrangements in a biological sample," describes a novel approach for detecting and visualizing polynucleotide sequences. This method utilizes specially designed probes to enhance resolution and simplify the detection of genomic rearrangements associated with various conditions, including cancer.

Career Highlights

Maurizio Ceppi is currently associated with Genomic Vision, a company dedicated to advancing genomic technologies. His work has been instrumental in developing diagnostic tools that can assess genetic predispositions and improve patient outcomes.

Collaborations

Ceppi collaborates with notable colleagues such as Emmanuel Conseiller and Jennifer Abscheidt, contributing to a dynamic research environment focused on innovative genomic solutions.

Conclusion

Maurizio Ceppi's contributions to genomic detection technologies are paving the way for advancements in understanding genetic predispositions to diseases. His innovative methods and collaborative efforts continue to impact the field significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…